TY - JOUR
T1 - X-linked chronic granulomatous disease
T2 - Mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase
AU - Rae, Julie
AU - Newburger, Peter E.
AU - Dinauer, Mary C.
AU - Noack, Deborah
AU - Hopkins, Penelope J.
AU - Kuruto, Ryoko
AU - Curnutte, John T.
N1 - Funding Information:
We thank Drs. Andrew Cross and Paul Heyworth, for their valuable advice, and Carolyn Padden and Constance Whitney, for their excellent technical assistance. This work was supported by National Institutes of Health grants AI24838, AI33346, DK41625, HL45635, and RR00833; by The March of Dimes; and by an award from the Howard Hughes Medical Institute, to the University of Massachusetts Medical School, under the Research Resources Program for Medical Schools.
PY - 1998/6
Y1 - 1998/6
N2 - Chronic granulomatous disease (CGD) is a hereditary disorder of host defense due to absent or decreased activity of phagocyte NADPH oxidase. The X-linked form of the disease derives from defects in the CYBB gene, which encodes the 91-kD glycoprotein component (termed 'gp91-phox') of the oxidase. We have identified the mutations in the CYBB gene responsible for X-linked CGD in 131 consecutive independent kindreds. Screening by SSCP analysis identified mutations in 124 of the kindreds, and sequencing of all exons and intron boundary regions revealed the other seven mutations. We detected 103 different specific mutations; no single mutation appeared in more than seven independent kindreds. The types of mutations included large and small deletions (11%), frameshifts (24%), nonsense mutations (23%), missense mutations (23%), splice-region mutations (17%), and regulatory-region mutations (2%). The distribution of mutations within the CYBB gene exhibited great heterogeneity, with no apparent mutational hot spots. Evaluation of 87 available mothers revealed X-linked carrier status in all but 10. The heterogeneity of mutations and the lack of any predominant genotype indicate that the disease represents many different mutational events, without a founder effect, as is expected for a disorder with a previously lethal phenotype.
AB - Chronic granulomatous disease (CGD) is a hereditary disorder of host defense due to absent or decreased activity of phagocyte NADPH oxidase. The X-linked form of the disease derives from defects in the CYBB gene, which encodes the 91-kD glycoprotein component (termed 'gp91-phox') of the oxidase. We have identified the mutations in the CYBB gene responsible for X-linked CGD in 131 consecutive independent kindreds. Screening by SSCP analysis identified mutations in 124 of the kindreds, and sequencing of all exons and intron boundary regions revealed the other seven mutations. We detected 103 different specific mutations; no single mutation appeared in more than seven independent kindreds. The types of mutations included large and small deletions (11%), frameshifts (24%), nonsense mutations (23%), missense mutations (23%), splice-region mutations (17%), and regulatory-region mutations (2%). The distribution of mutations within the CYBB gene exhibited great heterogeneity, with no apparent mutational hot spots. Evaluation of 87 available mothers revealed X-linked carrier status in all but 10. The heterogeneity of mutations and the lack of any predominant genotype indicate that the disease represents many different mutational events, without a founder effect, as is expected for a disorder with a previously lethal phenotype.
UR - http://www.scopus.com/inward/record.url?scp=0031777032&partnerID=8YFLogxK
U2 - 10.1086/301874
DO - 10.1086/301874
M3 - Article
C2 - 9585602
AN - SCOPUS:0031777032
SN - 0002-9297
VL - 62
SP - 1320
EP - 1331
JO - American journal of human genetics
JF - American journal of human genetics
IS - 6
ER -